LETTER TO THE EDITOR (Hepatitis B Virus Variants in HBV Mono-Infected Versus HBV/HIV Co-Infected Patients)

Seyed      Mohammad Jazayeri; Seyed      Moayed Alavian

doi:10.2174/157016212800618075

Author(s): Seyed Mohammad Jazayeri and Seyed Moayed Alavian

Volume 10, Issue 3, 2012

Page: [245 - 246] Pages: 2

DOI: 10.2174/157016212800618075

Abstract

Full text available

« Previous Next »

Download Options

Rights & Permissions Print Cite

Current HIV Research

Title:LETTER TO THE EDITOR (Hepatitis B Virus Variants in HBV Mono-Infected Versus HBV/HIV Co-Infected Patients)

Volume: 10 Issue: 3

Author(s): Seyed Mohammad Jazayeri and Seyed Moayed Alavian

Affiliation:

Abstract: Full text available

Export Options

Export File:

RIS (for EndNote, Reference Manager, ProCite)

BibTeX

Text

Content:

Citation Only

Citation and Abstract

About this article

Cite this article as:

Mohammad Jazayeri Seyed and Moayed Alavian Seyed, LETTER TO THE EDITOR (Hepatitis B Virus Variants in HBV Mono-Infected Versus HBV/HIV Co-Infected Patients), Current HIV Research 2012; 10 (3) . https://dx.doi.org/10.2174/157016212800618075

DOI https://dx.doi.org/10.2174/157016212800618075	Print ISSN 1570-162X
Publisher Name Bentham Science Publisher	Online ISSN 1873-4251

About this journal

Related Journals

Infectious Disorders - Drug Targets

Anti-Infective Agents

Recent Advances in Inflammation & Allergy Drug Discovery

Recent Advances in Anti-Infective Drug Discovery

Related Books

Frontiers in Clinical Drug Research: Anti-Infectives

Frontiers in Anti-Infective Drug Discovery

Coronaviruses

Moving From COVID-19 Mathematical Models to Vaccine Design: Theory, Practice and Experiences

COVID-19: Effects in Comorbidities and Special Populations

An Update on SARS-CoV-2: Damage-response Framework, Potential Therapeutic Avenues and the Impact of Nanotechnology on COVID-19 Therapy

An Epidemiological Update on COVID -19

Frontiers in Clinical Drug Research: Anti-Infectives

Frontiers in Anti-infective Agents

Coronavirus Disease-19 (COVID-19): A Perspective of New Scenario

Article Metrics

Journal Information

About Journal
Editorial Board
Current Issue
Volumes /Issues

For Authors

Author Guidelines
Graphical Abstracts
Fabricating and Stating False Information
Research Misconduct
Post Publication Discussions and Corrections
Publishing Ethics and Rectitude
Increase Visibility of Your Article
Archiving Policies
Peer Review Workflow
Order Your Article Before Print
Promote Your Article
Manuscript Transfer Facility
Editorial Policies
Allegations from Whistleblowers

For Editors

Guest Editor Guidelines
Editorial Management
Fabricating and Stating False Information
Publishing Ethics and Rectitude
Ethical Guidelines for New Editors
Peer Review Workflow

For Reviewers

Reviewer Guidelines
Peer Review Workflow
Fabricating and Stating False Information
Publishing Ethics and Rectitude

Explore Articles

Abstract Ahead of Print 1
Early View 5
Free Online Copy
Most Cited Articles
Most Accessed Articles
Editor's Choice
Thematic Issues

Open Access

Open Access Articles

For Visitors

Library Recommendation
Trial Requests
Advertise With Us
Meet the Executive Guest Editor(s)
Brand Ambassador
Author's Comment & Reviews
New Journals 2023
New Journals 2024
Alert Subscription
TOC Alert

Restricted Access Panel

Content Access Key Password

Current HIV Research

LETTER TO THE EDITOR (Hepatitis B Virus Variants in HBV Mono-Infected Versus HBV/HIV Co-Infected Patients)

Abstract Play Pause

Related Journals

Related Books

Abstract